no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008–2020
|
Orangzeb, Saima |
|
|
41 |
31 |
p. 4579-4585 |
article |
2 |
A diagnostic quandary: Rotavirus vaccine associated diarrhea
|
Hamel, Benjamin L. |
|
|
41 |
31 |
p. 4453-4456 |
article |
3 |
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
|
Puthanakit, Thanyawee |
|
|
41 |
31 |
p. 4541-4553 |
article |
4 |
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan
|
Ui, Masahiro |
|
|
41 |
31 |
p. 4534-4540 |
article |
5 |
Characterization of epitopes of human monoclonal antibodies against cytomegalovirus glycoprotein B for neutralization and antibody-dependent phagocytosis
|
Yamaguchi, Keisuke |
|
|
41 |
31 |
p. 4497-4507 |
article |
6 |
Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model
|
Sanders, Chelsea |
|
|
41 |
31 |
p. 4480-4487 |
article |
7 |
Editorial Board/Aims and Scope
|
|
|
|
41 |
31 |
p. IFC |
article |
8 |
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
|
de Gier, Brechje |
|
|
41 |
31 |
p. 4488-4496 |
article |
9 |
Estimation of baseline IgG antibody levels to 23 pneumococcal vaccine-type capsular polysaccharides in healthy vaccine naïve Indian adults
|
Govindan, Vandana |
|
|
41 |
31 |
p. 4447-4452 |
article |
10 |
Evaluation of protection and immunity induced by infectious bronchitis vaccines administered by oculonasal, spray or gel routes in commercial broiler chicks
|
Al-Rasheed, Mohammed |
|
|
41 |
31 |
p. 4508-4524 |
article |
11 |
How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separately
|
Ailloud, Julien |
|
|
41 |
31 |
p. 4594-4608 |
article |
12 |
Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States
|
Janoff, Edward N. |
|
|
41 |
31 |
p. 4571-4578 |
article |
13 |
Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective
|
Kato, Hiroaki |
|
|
41 |
31 |
p. 4625-4631 |
article |
14 |
Intraseasonal waning immunity of seasonal influenza vaccine – A systematic review and meta-analysis
|
Doyon-Plourde, Pamela |
|
|
41 |
31 |
p. 4462-4471 |
article |
15 |
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials
|
Dunn, David T. |
|
|
41 |
31 |
p. 4472-4479 |
article |
16 |
Optimizing the Immunogenicity of HIV Vaccines by Adjuvants – NIAID Workshop Report
|
Singh, Anjali |
|
|
41 |
31 |
p. 4439-4446 |
article |
17 |
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses
|
Nishiyama, Ayae |
|
|
41 |
31 |
p. 4525-4533 |
article |
18 |
Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device
|
Beyers, Koen C.L. |
|
|
41 |
31 |
p. 4609-4615 |
article |
19 |
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
|
Kozma, Gergely Tibor |
|
|
41 |
31 |
p. 4561-4570 |
article |
20 |
Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic
|
Nogareda, Francisco |
|
|
41 |
31 |
p. 4554-4560 |
article |
21 |
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study
|
Madran, Bahar |
|
|
41 |
31 |
p. 4586-4593 |
article |
22 |
Vaccination with HepB-CpG vaccine in individuals undergoing immune suppressive drug therapy
|
Perrillo, Robert |
|
|
41 |
31 |
p. 4457-4461 |
article |
23 |
Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust
|
Masoud, Dima |
|
|
41 |
31 |
p. 4616-4624 |
article |